02/14/2025
8:00 AM | RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
4:16 PM | Sage Therapeutics (Filer)
| Form POS AM | |
02/05/2025
9:41 AM | MORGAN STANLEY (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/31/2025
8:55 AM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
8:28 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
5:02 AM | BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
5:06 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:34 PM | BIOGEN INC. (Filed by)
Sage Therapeutics (Subject)
| Form SCHEDULE 13D | |
12/27/2024
3:11 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:47 PM | JONAS JEFFREY M (Reporting)
Sage Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for SAGE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/26/2024
3:42 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
5:40 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:14 PM | BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
3:56 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
2:28 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:10 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:23 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2024
3:24 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:10 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:20 PM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
10:37 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024
6:11 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
5:37 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
6:07 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:33 AM | Sage Therapeutics (Filer)
| Form S-3ASR | |
07/31/2024
3:10 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:15 PM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
5:39 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:57 PM | Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:57 PM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:57 PM | COLA MICHAEL F (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | Germano Geno J (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
11:15 AM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
06/10/2024
8:48 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
Nvidia > DeepSeek (Ad) Everyone's getting it all wrong …
Sure, DeepSeek's reveal caused AI stocks to tumble …
But, in the long run … that's a good thing. Click here to see why Nvidia's bad day could end up being a great year. |
06/06/2024
8:54 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/25/2024
6:15 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
5:46 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024
7:31 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:35 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:34 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free SAGE Stock Alerts